Fischer Medical Ventures Ltd — Results, 30-05-2025: Result

Fischer Medical Ventures Limited has announced a board meeting approving the financial results for the quarter and half-year ended March 31, 2025, reporting consolidated revenue from operations of ₹11069.87 lakhs and a consolidated net profit after tax of ₹120.79 lakhs for the year. Standalone revenue was ₹1152.83 lakhs with a loss of ₹66.32 lakhs. The auditors issued an unmodified opinion on both standalone and consolidated statements. The board decided to propose a final dividend of ₹0.05 per equity share for approval at the AGM. Bilimoria Mehta & Co. was recommended for re-appointment as statutory auditors, and S. Ramanand Aiyer & Co. as internal auditors for FY 2025-26. The company plans listing on NSE’s Main Board. During the year, it incorporated several subsidiaries including Wondertech Medical Solutions Pvt. Ltd., Fischer Hospitality Sdn. Bhd., and Nanyang Biologics (India) Pvt. Ltd., which are consolidated in the results. The consolidated balance sheet shows significant growth in assets and equity, driven by investments and share capital increase.